Selenium: Fact sheet for health professionals
Los agonistas GLP-1 aprobados por la FDA incluyen semaglutida inyectable (Ozempic para diabetes, Wegovy para control de peso), semaglutida oral (Rybelsus para diabetes), dulaglutida (Trulicity), liraglutida (Victoza para diabetes, Saxenda para control de peso) y exenatida (Bydureon BCise)
Different second mechanism, different molecular design, not interchangeable
While daily use before routine training is not necessarily recommended, strategic supplementation before high-load sessions, time trials, or competitions may help reduce perceived exertion and optimize fat oxidation
It is also frequently referenced in discussions surrounding advanced longevity research compounds and peptide-based cellular health optimisation protocols
Adderall can reduce awareness of thirst, and the gastrointestinal effects of Wegovy can increase fluid loss through nausea or diarrhoea in some people